Goldman Sachs’s Emmaus Life Sciences, Inc. Common Stock EMMA Stock Holding History

Goldman Sachs’s Portfolio EMMA Stock Details EMMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,969	Closed	-$15K	–	5523
2019 Q2	$15K	Buy	+1,969	New	+$14.6K	﹤0.01%	5068

Other funds holding EMMA

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Goldman Sachs's EMMA Position: Q3 2019 in Review

Goldman Sachs sold out of Emmaus Life Sciences, Inc. Common Stock (EMMA) in Q3 2019, closing a stake of 1,969 shares — an estimated $15K sold.

Goldman Sachs first reported a position in EMMA in Q2 2019 and held it in 1 quarter. The position peaked at $15K in Q2 2019. 1 fund tracked by Wall St. Rank holds EMMA as of Q3 2019.

Goldman Sachs reported no remaining Emmaus Life Sciences, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Goldman Sachs sold 1,969 Emmaus Life Sciences, Inc. Common Stock shares in Q3 2019, an estimated $15K.
Goldman Sachs first reported a position in Emmaus Life Sciences, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
Goldman Sachs's Emmaus Life Sciences, Inc. Common Stock position peaked at $15K in Q2 2019.
1 fund tracked by Wall St. Rank held Emmaus Life Sciences, Inc. Common Stock as of Q3 2019.

Based on Goldman Sachs's 13F filing for Q3 2019, filed 14 Nov 2019.